| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.09 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.1 |